Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in‐depth exploration of seven established risk factors

Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in‐depth exploration of seven established risk factors

Abstract Identifying the leading health and lifestyle factors for the risk of incident dementia and Alzheimer's disease has yet to translate to risk reduction. To understand why, we examined the discrepancies between observational and clinical trial evidence for seven modifiable risk factors: t...

Full description

Bibliographic Details
Main Authors: Ruth Peters, John Breitner, Sarah James, Gregory A. Jicha, Pierre‐Francois Meyer, Marcus Richards, A. David Smith, Hussein N. Yassine, Erin Abner, Atticus H. Hainsworth, Patrick G. Kehoe, Nigel Beckett, Christopher Weber, Craig Anderson, Kaarin J. Anstey, Hiroko H. Dodge
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
anti‐hypertensives
anti‐inflammatories
blood pressure
cholesterol
dementia
diabetes mellitus
Online Access:https://doi.org/10.1002/trc2.12202

Internet

https://doi.org/10.1002/trc2.12202

Similar Items